ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 316 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q2 2021. The put-call ratio across all filers is 0.51 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $721 | -78.9% | 26,840 | -71.9% | 0.00% | -75.0% |
Q2 2023 | $3,411 | +369.8% | 95,660 | +234.7% | 0.01% | +300.0% |
Q1 2023 | $726 | -36.5% | 28,584 | +1.4% | 0.00% | -33.3% |
Q4 2022 | $1,144 | -99.9% | 28,194 | +0.6% | 0.00% | 0.0% |
Q3 2022 | $926,000 | -5.2% | 28,015 | +1.0% | 0.00% | 0.0% |
Q2 2022 | $977,000 | -22.9% | 27,740 | +0.7% | 0.00% | +50.0% |
Q1 2022 | $1,267,000 | -58.4% | 27,558 | -34.7% | 0.00% | -66.7% |
Q4 2021 | $3,043,000 | +16.1% | 42,218 | +0.6% | 0.01% | +20.0% |
Q3 2021 | $2,620,000 | -25.3% | 41,980 | -0.9% | 0.01% | -28.6% |
Q2 2021 | $3,508,000 | -51.7% | 42,359 | -61.3% | 0.01% | -56.2% |
Q1 2021 | $7,257,000 | -19.3% | 109,434 | -6.6% | 0.02% | -23.8% |
Q4 2020 | $8,988,000 | +393.8% | 117,135 | +177.1% | 0.02% | +320.0% |
Q3 2020 | $1,820,000 | +49.9% | 42,268 | +50.3% | 0.01% | +25.0% |
Q2 2020 | $1,214,000 | +61.2% | 28,114 | +7.5% | 0.00% | +33.3% |
Q1 2020 | $753,000 | -54.6% | 26,157 | 0.0% | 0.00% | -40.0% |
Q4 2019 | $1,659,000 | -22.2% | 26,157 | -65.4% | 0.01% | -28.6% |
Q3 2019 | $2,132,000 | +8.9% | 75,659 | +2.4% | 0.01% | +16.7% |
Q2 2019 | $1,958,000 | – | 73,903 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Western Financial Corp/CA | 820,320 | $33,272,179 | 21.56% |
Aquilo Capital Management, LLC | 1,103,515 | $44,758,568 | 16.81% |
M28 Capital Management LP | 143,900 | $5,836,584 | 5.56% |
WEALTH EFFECTS LLC | 155,620 | $6,311,951 | 3.60% |
Evolutionary Tree Capital Management, LLC | 92,095 | $3,735,373 | 3.59% |
Privium Fund Management B.V. | 221,015 | $8,867,122 | 3.36% |
JOHNSON & JOHNSON | 247,598 | $10,043 | 2.92% |
COMMODORE CAPITAL LP | 462,111 | $18,743 | 2.82% |
Avidity Partners Management LP | 1,375,000 | $55,770,000 | 1.21% |
Capital Impact Advisors, LLC | 26,853 | $1,089,158 | 1.06% |